'Too costly' drug can slow dementia 'by up to eight years'

AN Alzheimer's drug deemed too costly for the NHS can slow progression of dementia by up to eight years, researchers claim.

- BY HANNA GEISSLER Health Editor

Medicines assessor NICE ruled in June that the benefits of two breakthrough therapies were too modest to justify the price, after trials showed they could delay progression from mild to moderate disease by four to six months. But new data for one of them, lecanemab, presented at a conference in the US, raises hope that its drug’s r